Hospira Books Indian Patent for ‘An Improved Process for the Preparation of Cilastatin’ - 19.10.2015

US-based Hospira, now a subsidiary of pharma major Pfizer Inc, has secured an Indian patent for an improved process for preparation of Cilastatin -part of a medical compound used in the treatment of a number of bacterial infections.

Tags : Hospira patentCilastatin

Share :